Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases - Details

author：

Yu, S. (Yu, S..) ^[1] | Liu, H. (Liu, H..) ^[3] | Liao, N. (Liao, N..) ^[4] | Liu, X. (Liu, X..) ^[5]

Indexed by：

Scopus

Abstract：

Although　mesenchymal　stem　cell　(MSC)　transplantation　provides　an　alternative　strategy　for　end-stage　liver　disease　(ESLD),　further　widespread　application　of　MSC　therapy　is　limited　owing　to　low　cell　engraftment　efficiency.　Improving　cell　engraftment　efficiency　plays　a　critical　role　in　enhancing　MSC　therapy　for　liver　diseases.　In　this　review,　we　summarize　the　current　status　and　challenges　of　MSC　transplantation　for　ESLD.　We　also　outline　the　complicated　cell-homing　process　and　highlight　how　low　cell　engraftment　efficiency　is　closely　related　to　huge　differences　in　extracellular　conditions　involved　in　MSC　homing　journeys　ranging　from　constant,　controlled　conditions　in　vitro　to　variable　and　challenging　conditions　in　vivo.　Improving　cell　survival　and　homing　capabilities　enhances　MSC　engraftment　efficacy.　Therefore,　we　summarize　the　current　strategies,　including　hypoxic　priming,　drug　pretreatment,　gene　modification,　and　cytokine　pretreatment,　as　well　as　splenectomy　and　local　irradiation,　used　to　improve　MSC　survival　and　homing　capability,　and　enhance　cell　engraftment　and　therapeutic　efficiency　of　MSC　therapy.　We　hope　that　this　review　will　provide　new　insights　into　enhancing　the　efficiency　of　MSC　engraftment　in　liver　diseases.　©　2023,　BioMed　Central　Ltd.,　part　of　Springer　Nature.

Keyword：

Cell survival Engraftment efficiency Liver diseases Mesenchymal stem cells MSC homing

Community：

[ 1 ] [Yu S.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 2 ] [Yu S.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 3 ] [Yu S.]The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, 350025, China
[ 4 ] [Yu S.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 5 ] [Yu S.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 6 ] [Yu S.]The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, 350025, China
[ 7 ] [Liu H.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 8 ] [Liu H.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 9 ] [Liu H.]The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, 350025, China
[ 10 ] [Liao N.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 11 ] [Liao N.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 12 ] [Liao N.]The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, 350025, China
[ 13 ] [Liu X.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China
[ 14 ] [Liu X.]Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, China
[ 15 ] [Liu X.]The Liver Center of Fujian Province, Fujian Medical University, Fuzhou, 350025, China

Reprint 's Address：

Email：

Show more details

Related Keywords：

Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases
2023，STEM CELL RESEARCH & THERAPY
Antioxidant preconditioning improves therapeutic outcomes of adipose tissue-derived mesenchymal stem cells through enhancing intrahepatic engraftment efficiency in a mouse liver fibrosis model
2020，STEM CELL RESEARCH & THERAPY
Reduced glutathione enhances adipose tissue-derived mesenchymal stem cell engraftment efficiency for liver fibrosis by targeting TGFβ1/SMAD3/NOX4 pathway
2024，BIOENGINEERING & TRANSLATIONAL MEDICINE
Enhancing therapeutic effects and in vivo tracking of adipose tissue-derived mesenchymal stem cells for liver injury using bioorthogonal click chemistry
2021，NANOSCALE
Immunomodulatory role of mesenchymal stem cells in liver transplantation: status and prospects
2023，DIGESTIVE DISEASES

Source ：

Stem Cell Research and Therapy

ISSN： 1757-6512

Year： 2023

Issue： 1

Volume： 14

4 . 6 2 7

JCR@2018

CAS Journal Grade：2

Cited Count：

WoS CC Cited Count：

SCOPUS Cited Count： 25

ESI Highly Cited Papers on the List： 0 Unfold All

WanFang Cited Count：

Chinese Cited Count：

30 Days PV： 2

Affiliated Colleges：

Get Fulltext

DOI Library Discovery Baidu Scholar Search SCOPUS

Type
Departments

All Years Choose Year From to